Intent to sole source for BEST 1 Bridge Contract to Acumen LLC

The FDA intends to award a sole-source contract to Acumen LLC for the Biologics Effectiveness and Safety (BEST) Initiative. The contract will support the coordinating center for the BEST Initiative, which serves as the central hub for managing all aspects of the program. The coordinating center will provide program management, technical infrastructure, analytical capabilities, scientific support, and administrative oversight to ensure the timely and consistent execution of surveillance studies. The key responsibilities of the contract include ensuring uninterrupted management and coordination of activities, maintaining analytic capacity, and avoiding costly delays or disruptions in mission-critical operations. The contract will have a duration of 12 months and a total value of approximately $6 million. Key aspects of the job include: • Ensuring continuity across projects and supporting knowledge management • Maintaining the technical infrastructure needed to support standardized data transformation and querying • Providing program management, technical infrastructure, analytical capabilities, scientific support, and administrative oversight • Ensuring the timely and consistent execution of surveillance studies conducted through separate contracts with data partners • Supporting the administration of task orders, coordination of data partners, project tracking, timeline oversight, and quality control across active surveillance activities